ReviewNanomedicine (London, England)2025
Advancements in nanoultrasonics technology for the diagnosis and treatment of liver cancer: discussion on medical ethics and hospital management issues.
Review in Nanomedicine (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Application of multimodal nanotechnology and standardized nursing management in ventricular arrhythmia.Biomedical engineering online · 2026Review
- SCAG-Net: Automated Brain Tumor Prediction from MRI Using Cuttlefish-Optimized Attention-Based Graph Networks.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The field of nanoultrasonics technology has emerged as a promising avenue for enhancing the diagnosis and treatment of liver cancer, a disease characterized by high mortality rates and complex management challenges. Recent studies highlight the potential of this innovative technology in improving early detection rates and enabling precision therapies, which are crucial for better patient outcomes. Despite these advancements, several issues persist within the realm of clinical application, particularly concerning medical ethics and hospital management practices. This review aims to synthesize the latest research developments in nanoultrasonics technology, focusing on its benefits in liver cancer diagnostics and treatment. Additionally, it will explore the ethical considerations and administrative challenges that arise during its implementation in clinical settings. By addressing these aspects, the review seeks to provide a comprehensive understanding of the current landscape and offer guidance for the standardized application of this technology in the future, ultimately contributing to improved patient care in liver cancer management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.